| BMI | Body mass index |
| GLP-1 | Glucagon-like peptide-1 |
| GIP | Gastric inhibitory polypeptide |
| DPP-4 | Dipeptidyl peptidase 4 |
| cAMP | Cyclic adenosine monophosphate |
| HOMA-IR | Homeostasis Model Assessment of Insulin Resistance |
| OGTT | Oral glucose tolerance test |
| TM | Transmembrane |
| BID | Twice per day |
| NA | Not available |
| GI | Gastrointestinal |
| AE | Adverse event |
| ADA | American Diabetes Association |
| TEAE | Treatment-emergent adverse event |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.